Regen BioPharma
(OTCPK:RGBPP)
0.0263
00
At close: May 23
15 minutes delayed

Regen BioPharma (OTC:RGBPP), Quotes and News Summary

Regen BioPharma (OTC: RGBPP)

There is no Press for this Ticker
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.

Regen BioPharma Questions & Answers

Q
How do I buy Regen BioPharma (RGBPP) stock?
A

You can purchase shares of Regen BioPharma (OTCPK: RGBPP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Regen BioPharma's (RGBPP) competitors?
A

There are no as such competitors for Regen BioPharma.

Q
What is the target price for Regen BioPharma (RGBPP) stock?
A

There is no analysis for Regen BioPharma

Q
Current Stock Price for Regen BioPharma (RGBPP)?
A

The stock price for Regen BioPharma (OTCPK: RGBPP) is $0.0263 last updated May 23, 2022, 7:59 PM UTC.

Q
Does Regen BioPharma (RGBPP) pay a dividend?
A

There are no upcoming dividends for Regen BioPharma.

Q
When is Regen BioPharma (OTCPK:RGBPP) reporting earnings?
A

Regen BioPharma does not have any upcoming earnings scheduled.

Q
Is Regen BioPharma (RGBPP) going to split?
A

There is no upcoming split for Regen BioPharma.

Q
What sector and industry does Regen BioPharma (RGBPP) operate in?
A

Regen BioPharma is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.